உர்சூல உங்கறோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from உர்சூல உங்கறோ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In உர்சூல உங்கறோ Today - Breaking & Trending Today
Longeveron Announces the Appointment of Ursula Ungaro to its Board of Directors May 25, 2021 09:00 ET | Source: Longeveron Longeveron Miami, Florida, UNITED STATES MIAMI, May 25, 2021 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ: LGVN) ( Longeveron or Company ), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today that Ursula Ungaro will be joining its Board of Directors as of June 1, 2021. Ms. Ungaro was appointed to serve on the federal U.S. District Court for the Southern District of Florida in 1992 after being nominated by President George H.W. Bush and being confirmed by the U.S. Senate. After 29 years of federal service, Ms. Ungaro has announced that she will be retiring from the bench on May 31, 2021. In her time on the federal bench, she presided over and ruled in numerous major civil and criminal cases i ....
Longeveron Announces the Appointment of Ursula Ungaro to its Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Longeveron (LGVN) Announces the Appointment of Ursula Ungaro to its Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Print A seminal research paper in the saga of questionable stem cell medical treatments has just been retracted, largely due to ethical concerns. The 2017 paper touted the safety of injecting stem cells derived from patients’ fat cells into their arthritic knees. It implied that the treatment was successful in its sample of 10 patients. Its purported conclusions were then broadcast by U.S. Stem Cell, a Florida clinic that has since come under legal fire by the Food and Drug Administration. In 2019, the FDA obtained a permanent injunction from federal court forbidding the firm from continuing its treatments. The Editor-in-Chief.no longer has confidence in the reliability of the data reported in the article. ....